Abstract
Abstract
Background
Bone marrow assessment is an important part in the Ann Arbor staging system in lymphoma. It is done routinely through posterior iliac crest bone marrow biopsy (BMB) which is an invasive technique with limited examination of one site. 18F-FDG PET/CT is now used for staging of lymphoma. The purpose of this study was to compare the sensitivity of PET/CT and BMB in detecting bone marrow infiltration (BMI) in lymphoma and determine agreement between both in assessing bone marrow and whether we can evaluate the bone marrow by PET/CT without the need of the routine BMB.
Results
PET/CT detected 24 (16.5%) cases with positive BMI that were missed by BMB. BMB detected only 2 (1.4%) cases that were missed by PET/CT. The PET/CT showed a higher sensitivity of 95.6% than BMB 46.7% in detecting BMI in lymphoma. We found a moderate agreement between PET/CT and BMB results in the whole cohort using Cohen’s k computation. It was found that 0.47 with p value less than 0.0001.
Conclusions
PET/CT can detect more bone marrow involvement in lymphoma compared with BMB. It can replace the routine invasive BMB in many cases, especially those showing multifocal uptake in both Hodgkin and non-Hodgkin lymphoma. PET/CT can also help to guide the site of the biopsy in some cases. Iliac crest BMB is still needed in cases showing diffuse FDG uptake to differentiate malignant uptake from reactive hyperplasia, and in those with limited FDG avidity and in some cases with negative uptake to exclude early infiltration if management will differ.
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging
Reference35 articles.
1. Cheng G, Chen W, Chamroonrat W, Torigian DA, Zhuang H, Alavi A (2011) Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients. Eu J Nuclear Med Molecular Imaging 38(8):1469–1476. https://doi.org/10.1007/s00259-011-1815-z
2. Levis A, Pietrasanta D, Godio L, Vitolo U, Ciravegna G, Di Vito F et al (2004) A large-scale study of bone marrow involvement in patients with Hodgkin's lymphoma. Clinical lymphoma 5(1):50–55 https://doi.org/10.3816/CLM.2004.n.010
3. Ponzoni, M., Ciceri, F., Crocchiolo, R., Famoso, G., & Doglioni, C. (2006). Isolated bone marrow occurrence of classic Hodgkin's lymphoma in an HIV-negative patient. haematologica, 91(3), ECR04-ECR04. Retrieved from http://www.haematologica.org/content/91/3/ECR04
4. Hassan, A., Siddique, M., Bashir, H., Riaz, S., Wali, R., Mahreen, A., & Nawaz, M. K. (2017). 18 F-FDG PET-CT imaging versus bone marrow biopsy in pediatric Hodgkin’s lymphoma: a quantitative assessment of marrow uptake and novel insights into clinical implications of marrow involvement. Eu J Nuclear Med Molecular Imaging, 44(7), 1198-1206. https://doi.org/10.1007/s00259-017-3647-y
5. Vishnu P, Wingerson A, Lee M, Mandelson MT, Aboulafia DM (2017) Utility of bone marrow biopsy and aspirate for staging of diffuse large B cell lymphoma in the era of positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro-deoxyglucose integrated with computed tomography. Clinical Lymphoma Myeloma and Leukemia 17(10):631–636. https://doi.org/10.1016/j.clml.2017.06.010